A Virtual Event | May 4-5, 2021

Image

The Psychedelic Therapeutics and Drug Development Conference has been organized to bring together the world’s leading researchers and leaders in academia and industry to discuss the challenges and opportunities facing those engaged in the research and development of psychedelics for various health conditions with considerable unmet need. This event will highlight the progress being made towards regulatory approval of a variety of psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.

Conference Themes

  • Clinical trial design
  • Risk Evaluation & Mitigation Strategy (REMS)
  • Abuse potential
  • Practical use/indications/
  • DEA licensure & policy considerations
  • Targets for novel drug development
  • Dosage (micro/low/high)
  • Second generation psychedelic drug design
  • FDA regulatory guidance
  • Toxicology studies and considerations

Featured Speakers

Bryan Roth, MD, Ph.D.
Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Professor
University of North Carolina School of Medicine
Charles Nichols, Ph.D.
Charles Nichols, Ph.D.Professor, Department of Pharmacology & Experimental Therapeutics
LSU Health Sciences Center
Frederick Barrett, Ph.D.
Frederick Barrett, Ph.D.Assistant Professor of Psychiatry & Behavioral Sciences
Johns Hopkins School of Medicine

Reasons to Attend

Discover & Learn

Learn about the latest developments in the field of psychedelics research and better understand the path forward for clinical development.

Meet, Network & Re-connect

Utilize our mobile and web-based platforms to meet and network with colleagues before, during and after the event.

Navigate Regulatory & Policy Challenges

Learn about and navigate the regulatory and policy challenges facing developers of psychedelic-based therapies.

Who Should Attend

Chief Executive Officers
Vice Presidents
Chief Medical Officers
Business Development Professionals
Regulatory Affairs Professionals
Research Scientists
R&D Professionals
Clinical Development Professionals
Licensing Professionals
Investigators
Medical Chemists
Chemists
Pharmacists
Scientists
Study Managers
Project Managers
Scientific Officers
Professors
Ph.D./Pharm.D. Students
Health Care Practitioners
Program Officers
Investors
Analysts
Medical Directors